DRUG
ACTION
USES
TOXICITY · MONITOR
K⁺ block (plus Na⁺, β, Ca²⁺ effects) → ↑ AP duration, ↑ QT
AF (rhythm or rate), VT, VF arrest
Lungs, thyroid, liver, eyes, skin, nerves · PFTs, TFTs, LFTs
Amiodarone analog without iodine
AF maintenance
Contraindicated in HF (↑ mortality), permanent AF
K⁺ block + nonselective β-block
AF, ventricular arrhythmias
Torsades (dose by renal function), bradycardia
Pure IKr block
AF/flutter conversion and maintenance
Torsades — start in hospital with QT monitoring
L-type Ca²⁺ block in SA and AV nodes → ↓ phase 0 and 4 there, ↑ PR
SVT, AF/flutter rate control, angina, HTN
Bradycardia, AV block, constipation, HF worsening; ↑ digoxin level
A1 (Gi) in AV node → K⁺ efflux, hyperpolarization
Terminate AVNRT/AVRT; unmask flutter waves
Flushing, chest tightness, bronchospasm, brief asystole
Stabilizes membrane; blocks Ca²⁺ currents
Torsades de pointes, digoxin toxicity arrhythmias
Hypotension, ↓ reflexes
↑ Vagal tone → slows AV node
AF rate control in HF
Toxicity: atrial tachycardia with block, bidirectional VT
M2 block
Symptomatic sinus bradycardia, nodal block
Ineffective in infranodal block → pace
If block in SA node
Inappropriate sinus tachycardia, HF
Phosphenes
Class IA, III, macrolides, fluoroquinolones, antipsychotics, methadone, ondansetron, TCAs
Worse with ↓ K⁺, ↓ Mg²⁺, bradycardia, female sex
Treat: IV Mg²⁺, correct K⁺, overdrive pacing or isoproterenol